HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
P&K Skin Research Center Co.,Ltd. Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.	South Korea	347740
Plantarc Bio Ltd. Developing high-yield, resilient crops via gene discovery for global seed companies.	Israel	PLNT
Polymetal International plc A top global gold and silver producer with mining and exploration operations in Kazakhstan.	Kazakhstan	POLY
Poxel Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.	France	POXEL
PRAP Japan,Inc. A PR & communications firm building brand reputation for corporate clients in diverse industries.	Japan	2449
Predictive Oncology Inc. AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.	United States of America	POAI
Prime Medicine, Inc. Developing 'search and replace' gene editing therapies to treat genetic disorders.	United States of America	PRME
ProPhase Labs, Inc. Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.	United States of America	PRPH
PROTHENA CORP PUBLIC LTD CO Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.	United States of America	PRTA
Psomagen, Inc. A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.	United States of America	950200